Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases

Neurobiology of Disease

Volumn 46, Issue 2, 2012, Pages 325-335

  Cantuti Castelvetri, Ludovico ^a   Zhu, Hongling ^a   Givogri, Maria I ^a   Chidavaenzi, Robstein L ^a   Lopez Rosas, Aurora ^a   Bongarzone, Ernesto R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Axonal degeneration; Axonal transport; Dying back pathology; Kinases; Krabbe disease; Leukodystrophies; Myelin; Neurofilament; Phosphatases; Twitcher

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PSYCHOSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DEPHOSPHORYLATION; GLOBOID CELL LEUKODYSTROPHY; IN VITRO STUDY; MOTONEURON; MOUSE; NERVE FIBER; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE;

ANIMALS; CELLS, CULTURED; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN SHEATH; NEURAL INHIBITION; NEUROFILAMENT PROTEINS; NEUROTOXINS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; PSYCHOSINE; UP-REGULATION;

EID: 84863404661     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.01.013     Document Type: Article

References (76)

1. Aguayo A.J., Kasarjian J., Skamene E., Kongshavn P., Bray G.M. Myelination of mouse axons by Schwann cells transplanted from normal and abnormal human nerves. Nature 1977, 268:753-755.
2. Aicardi J. The inherited leukodystrophies: a clinical overview. J. Inherit. Metab. Dis. 1993, 16:733-743.
3. Atkinson T., Whitfield J., Chakravarthy B. The phosphatase inhibitor, okadaic acid, strongly protects primary rat cortical neurons from lethal oxygen-glucose deprivation. Biochem. Biophys. Res. Commun. 2009, 378:394-398.
4. Berrou E., Bryckaert M. Recruitment of protein phosphatase 2A to dorsal ruffles by platelet-derived growth factor in smooth muscle cells: dephosphorylation of Hsp27. Exp. Cell Res. 2009, 315:836-848.
5. Bongarzone E.R., Foster L.M., Byravan S., Verity A.N., Landry C.F., Schonmann V., Amur-Umarjee S., Campagnoni A.T. Conditionally immortalized neural cell lines: potential models for the study of neural cell function. Methods 1996, 10:489-500.
6. Brownlees J., Ackerley S., Grierson A.J., Jacobsen N.J., Shea K., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 2002, 11:2837-2844.
7. Castelvetri L.C., Givogri M.I., Zhu H., Smith B., Lopez-Rosas A., Qiu X., van Breemen R., Bongarzone E.R. Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol. 2011, 122:35-48.
8. Cohen P.T. Protein phosphatase 1-targeted in many directions. J. Cell Sci. 2002, 115:241-256.
9. Cole J.S., Messing A., Trojanowski J.Q., Lee V.M. Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice. J. Neurosci. 1994, 14:6956-6966.
10. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 2005, 6:889-898.
11. de Waegh S.M., Brady S.T. Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts. J. Neurosci. Res. 1991, 30:201-212.
12. de Waegh S.M., Lee V.M., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992, 68:451-463.
13. Dolcetta D., Amadio S., Guerrini U., Givogri M.I., Perani L., Galbiati F., Sironi L., Del Carro U., Roncarolo M.G., Bongarzone E. Myelin deterioration in Twitcher mice: motor evoked potentials and magnetic resonance imaging as in vivo monitoring tools. J. Neurosci. Res. 2005, 81:597-604.
14. Dolcetta D., Perani L., Givogri M.I., Galbiati F., Amadio S., Del Carro U., Finocchiaro G., Fanzani A., Marchesini S., Naldini L., Roncarolo M.G., Bongarzone E. Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain. J. Gene Med. 2006, 8:962-971.
15. Eglitis M.A., Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4080-4085.
16. Elder G.A., Friedrich V.L., Kang C., Bosco P., Gourov A., Tu P.H., Zhang B., Lee V.M., Lazzarini R.A. Requirement of heavy neurofilament subunit in the development of axons with large calibers. J. Cell Biol. 1998, 143:195-205.
17. Eng S.R., Gratwick K., Rhee J.M., Fedtsova N., Gan L., Turner E.E. Defects in sensory axon growth precede neuronal death in Brn3a-deficient mice. J. Neurosci. 2001, 21:541-549.
18. Escolar M.L., Poe M.D., Provenzale J.M., Richards K.C., Allison J., Wood S., Wenger D.A., Pietryga D., Wall D., Champagne M., Morse R., Krivit W., Kurtzberg J. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N. Engl. J. Med. 2005, 352:2069-2081.
19. Galbiati F., Givogri M.I., Cantuti L., Lopez Rosas A., Cao H., van Breemen R., Bongarzone E.R. Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease. J. Neurosci. Res. 2009, 87:1748-1759.
20. Garcia M.L., Lobsiger C.S., Shah S.B., Deerinck T.J., Crum J., Young D., Ward C.M., Crawford T.O., Gotow T., Uchiyama Y., Ellisman M.H., Calcutt N.A., Cleveland D.W. NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J. Cell Biol. 2003, 163:1011-1020.
21. Gotow T. Neurofilaments in health and disease. Med. Electron Microsc. 2000, 33:173-199.
22. Hirano A., Donnenfeld H., Sasaki S., Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1984, 43:461-470.
23. Hisanaga S., Hirokawa N. The effects of dephosphorylation on the structure of the projections of neurofilament. J. Neurosci. 1989, 9:959-966.
24. Hogan G.R., Gutmann L., Chou S.M. The peripheral neuropathy of Krabbe's (globoid) leukodystrophy. Neurology 1969, 19:1094-1100.
25. Hsieh S.T., Crawford T.O., Griffin J.W. Neurofilament distribution and organization in the myelinated axons of the peripheral nervous system. Brain Res. 1994, 642:316-326.
26. Igisu H., Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 1984, 224:753-755.
27. Ikeda K., Zhapparova O., Brodsky I., Semenova I., Tirnauer J.S., Zaliapin I., Rodionov V. CK1 activates minus-end-directed transport of membrane organelles along microtubules. Mol. Biol. Cell 2011, 22:1321-1329.
28. Jacobs J.M., Scaravilli F., De Aranda F.T. The pathogenesis of globoid cell leucodystrophy in peripheral nerve of the mouse mutant twitcher. J. Neurol. Sci. 1982, 55:285-304.
29. Kanazawa T., Nakamura S., Momoi M., Yamaji T., Takematsu H., Yano H., Sabe H., Yamamoto A., Kawasaki T., Kozutsumi Y. Inhibition of cytokinesis by a lipid metabolite, psychosine. J. Cell Biol. 2000, 149:943-950.
30. Kim S.K., Kim H., Yang Y.R., Suh P.G., Chang J.S. Phosphatidylinositol phosphates directly bind to neurofilament light chain (NF-L) for the regulation of NF-L self assembly. Exp. Mol. Med. 2011, 43:153-160.
31. Kirkpatrick L.L., Brady S.T. Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. J. Neurosci. 1994, 14:7440-7450.
32. Kobayashi S., Katayama M., Satoh J., Suzuki K., Suzuki K. The twitcher mouse. An alteration of the unmyelinated fibers in the PNS. Am. J. Pathol. 1988, 131:308-319.
33. Kondo A., Hoogerbrugge P.M., Suzuki K., Poorthuis B.J., Van Bekkum D.W., Suzuki K. Pathology of the peripheral nerve in the twitcher mouse following bone marrow transplantation. Brain Res. 1988, 460:178-183.
34. Krivit W., Lockman L.A., Watkins P.A., Hirsch J., Shapiro E.G. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J. Inherit. Metab. Dis. 1995, 18:398-412.
35. Kumar S., Hoh J.H. Modulation of repulsive forces between neurofilaments by sidearm phosphorylation. Biochem. Biophys. Res. Commun. 2004, 324:489-496.
36. Lechward K., Awotunde O.S., Swiatek W., Muszynska G. Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochim. Pol. 2001, 48:921-933.
37. Lin L., Lee V.M., Wang Y., Lin J.S., Sock E., Wegner M., Lei L. Sox11 regulates survival and axonal growth of embryonic sensory neurons. Dev. Dyn. 2011, 240:52-64.
38. Martin J.J., Ceuterick C., Martin L., Leroy J.G., Nuyts J.P., Joris C. Globoid cell leucodystrophy (Krabbe's disease). Peripheral nerve lesion (author's transl). Acta Neurol. Belg. 1974, 74:356-375.
39. Mata M., Kupina N., Fink D.J. Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J. Neurocytol. 1992, 21:199-210.
40. Morfini G., Szebenyi G., Elluru R., Ratner N., Brady S.T. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 2002, 21:281-293.
41. Morfini G., Szebenyi G., Brown H., Pant H.C., Pigino G., DeBoer S., Beffert U., Brady S.T. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 2004, 23:2235-2245.
42. Morfini G., Pigino G., Szebenyi G., You Y., Pollema S., Brady S.T. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 2006, 9:907-916.
43. Morfini G.A., Burns M., Binder L.I., Kanaan N.M., LaPointe N., Bosco D.A., Brown R.H., Brown H., Tiwari A., Hayward L., Edgar J., Nave K.A., Garberrn J., Atagi Y., Song Y., Pigino G., Brady S.T. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 2009, 29:12776-12786.
44. Mukhopadhyay A., Saddoughi S.A., Song P., Sultan I., Ponnusamy S., Senkal C.E., Snook C.F., Arnold H.K., Sears R.C., Hannun Y.A., Ogretmen B. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. FASEB J. 2009, 23:751-763.
45. Nguyen M.D., Lariviere R.C., Julien J.P. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12306-12311.
46. Nixon R.A., Paskevich P.A., Sihag R.K., Thayer C.Y. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J. Cell Biol. 1994, 126:1031-1046.
47. Olmstead C.E. Neurological and neurobehavioral development of the mutant 'twitcher' mouse. Behav. Brain Res. 1987, 25:143-153.
48. Pant H.C., Veeranna Neurofilament phosphorylation. Biochem. Cell Biol. 1995, 73:575-592.
49. Pappolla M.A. Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments. Arch. Pathol. Lab. Med. 1986, 110:1160-1163.
50. Perrot R., Berges R., Bocquet A., Eyer J. Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol. Neurobiol. 2008, 38:27-65.
51. Rao M.V., Campbell J., Yuan A., Kumar A., Gotow T., Uchiyama Y., Nixon R.A. The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate. J. Cell Biol. 2003, 163:1021-1031.
52. Reles A., Friede R.L. Axonal cytoskeleton at the nodes of Ranvier. J. Neurocytol. 1991, 20:450-458.
53. Roy S., Coffee P., Smith G., Liem R.K., Brady S.T., Black M.M. Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J. Neurosci. 2000, 20:6849-6861.
54. Sakai N., Inui K., Tatsumi N., Fukushima H., Nishigaki T., Taniike M., Nishimoto J., Tsukamoto H., Yanagihara I., Ozono K., Okada S. Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease. J. Neurochem. 1996, 66:1118-1124.
55. Schlaepfer W.W., Prensky A.L. Quantitative and qualitative study of sural nerve biopsies in Krabbe's disease. Acta Neuropathol. 1972, 20:55-66.
56. Shah J.V., Flanagan L.A., Janmey P.A., Leterrier J.F. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol. Biol. Cell 2000, 11:3495-3508.
57. Shea T.B., Flanagan L.A. Kinesin, dynein and neurofilament transport. Trends Neurosci. 2001, 24:644-648.
58. Shen J.S., Watabe K., Ohashi T., Eto Y. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Gene Ther. 2001, 8:1081-1087.
59. Smith B., Galbiati F., Cantuti-Castelvetri L., Givogri M.I., Lopez-Rosas A., Bongarzone E.R. Peripheral neuropathy in the Twitcher mouse involves the activation of axonal caspase 3. ASN Neuro 2011, 3:213-222.
60. Strack S., Westphal R.S., Colbran R.J., Ebner F.F., Wadzinski B.E. Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res. Mol. Brain Res. 1997, 49:15-28.
61. Suzuki K. Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem. Res. 1998, 23:251-259.
62. Szebenyi G., Morfini G.A., Babcock A., Gould M., Selkoe K., Stenoien D.L., Young M., Faber P.W., MacDonald M.E., McPhaul M.J., Brady S.T. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 2003, 40:41-52.
63. Takei Y., Teng J., Harada A., Hirokawa N. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J. Cell Biol. 2000, 150:989-1000.
64. Taniike M., Suzuki K. Spacio-temporal progression of demyelination in twitcher mouse: with clinico-pathological correlation. Acta Neuropathol. 1994, 88:228-236.
65. Theiss C., Napirei M., Meller K. Impairment of anterograde and retrograde neurofilament transport after anti-kinesin and anti-dynein antibody microinjection in chicken dorsal root ganglia. Eur. J. Cell Biol. 2005, 84:29-43.
66. Toyoshima E., Yeager A.M., Brennan S., Santos G.W., Moser H.W., Mayer R.F. Nerve conduction studies in the Twitcher mouse (murine globoid cell leukodystrophy). J. Neurol. Sci. 1986, 74:307-318.
67. Virshup D.M., Shenolikar S. From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 2009, 33:537-545.
68. Wagner O.I., Ascano J., Tokito M., Leterrier J.F., Janmey P.A., Holzbaur E.L. The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. Mol. Biol. Cell 2004, 15:5092-5100.
69. Wang Y., Zhang J., Mori S., Nathans J. Axonal growth and guidance defects in Frizzled3 knock-out mice: a comparison of diffusion tensor magnetic resonance imaging, neurofilament staining, and genetically directed cell labeling. J. Neurosci. 2006, 26:355-364.
70. Wenger D.A., Rafi M.A., Luzi P., Datto J., Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol. Genet. Metab. 2000, 70:1-9.
71. White A.B., Givogri M.I., Lopez-Rosas A., Cao H., van Breemen R., Thinakaran G., Bongarzone E.R. Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture. J. Neurosci. 2009, 29:6068-6077.
72. White A.B., Givogri M.I., Lopez Rosas A., Qiu X., van Breemen R., Bongarzone E.R. Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease. J. Neurosci. Res. 2010, 89:352-364.
73. Windebank A.J., Wood P., Bunge R.P., Dyck P.J. Myelination determines the caliber of dorsal root ganglion neurons in culture. J. Neurosci. 1985, 5:1563-1569.
74. Wu Y.P., Matsuda J., Kubota A., Suzuki K., Suzuki K. Infiltration of hematogenous lineage cells into the demyelinating central nervous system of twitcher mice. J. Neuropathol. Exp. Neurol. 2000, 59:628-639.
75. Yabe J.T., Pimenta A., Shea T.B. Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J. Cell Sci. 1999, 112(Pt 21):3799-3814.
76. Zhu Q., Couillard-Després S., Julien J.P. Delayed maturation of myelinated axons in mice lacking neurofilaments. Exp. Neurol. 1997, 148:299-316.